viewSevern Trent

Severn Trent ups dividend despite expected rise in bad debt from coronavirus

The water company recorded a bad debt charge of £42.5mln for the past year and said it “expects to see an increase in bad debt from higher unemployment and stressed household finances” related to Covid-19

Severn Trent -

Severn Trent PLC (LON:SVT) has proposed a 7% increase to its dividend alongside its final results. 

A final dividend of 60.05p, which the water company said was in line with its policy, made for a full year payout of 100.08p compared to 93.37p a year ago.

The FTSE 100 group said its operations had remained resilient in the coronavirus crisis, adding that it has supported customers struggling to pay their bills and made £3.5mln available to further support those in need.

Turnover for the year to 31 March of £1.8bn was up 4% on the prior year, with reported profit before tax up 1% to £568mln.

Profit after tax tumbled 50% to £159mln.after an exceptional loss of £46.8mln from impairment of its long-term assets, bad debt charges, trading losses recorded before the impact of the virus and a £91.8mln exceptional deferred tax charge,

Severn Trent said it was “well-positioned to manage the financial impacts of Covid-19” with £755mln undrawn debt facilities, £200mln raised from a US bond sale and less than 2.5% of debt maturing in the coming year.

Having recorded a bad debt charge of £42.5mln for the past year, of which just £2.2mln was direct Covid-19 risks, the group said it “expects to see an increase in bad debt from higher unemployment and stressed household finances... and expect to see further Covid-19 related increases to our bad debt in future periods, based on the latest economic forecasts”.

The pension deficit was almost halved to £234mln reflecting a temporary spike in credit spreads at year-end and a lower long-term inflation forecast.

Shares in the company rose more than 1% on Wednesday morning to 2,435p, down around 3% since the start of the year.

Quick facts: Severn Trent


Price: 2773 GBX

Market Cap: £6.94 billion

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...


Redx Pharma presents at European Society for Medical Oncology (ESMO) Congress

Redx Pharma PLC's (LON:REDX) Lisa Anson joins Proactive London on the same day as the company present research at the European Society for Medical Oncology (ESMO) Congress. The firm presented the data from the phase I trial of its RXC004 monotherapy study which is their lead drug candidate,...

1 hour, 47 minutes ago

2 min read